NUMA1 anticorps (C-Term)
Aperçu rapide pour NUMA1 anticorps (C-Term) (ABIN928379)
Antigène
Voir toutes NUMA1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Réactivité croisée
- Rat (Rattus), Souris, Poulet, Grenouille
-
Purification
- Purified
-
Immunogène
- NUMA1 antibody was raised in rabbit using the C terminal of NUMA1 as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
NUMA1 Blocking Peptide, (ABIN936841), is also available for use as a blocking control in assays to test for specificity of this NUMA1 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- NUMA1 (Nuclear Mitotic Apparatus Protein 1 (NUMA1))
-
Autre désignation
- NUMA1
-
Sujet
- NuMA is a structural element in maintaining nuclear integrity. A critical spindle pole-associated mechanism, called the END (Emi1/NuMA/dynein-dynactin) network, spatially restricts APC/C activity in early mitosis. The entire coding region and exon-intron boundaries of NuMa were screened in 92 familial breast cancer patients. But the results do not support the role of NuMA variants as breast cancer susceptibility alleles. Synonyms: Polyclonal NUMA1 antibody, Anti-NUMA1 antibody, nuclear mitotic apparatus protein 1 antibody, NUMA antibody.
-
Pathways
- Caspase Cascade in Apoptosis, Regulation of Actin Filament Polymerization, M Phase
Antigène
-